Aarti Pharmalabs Q4 Results

  • BSE: 543748
  • NSE: AARTIPHARM
  • ISIN: INE0LRU01027
  • Sector: -
BSE
604.59.00 (1.51%)
Volume5.77 K
Updated: Fri 14 Jun, 2024 | 15:29:22
NSE
606.159.75 (1.63%)
Volume1.61 L
Updated: Fri 14 Jun, 2024 | 15:44:17
Today: 592.30
611.00
52-Wk: 321.00
638.95

Q4 Results Highlights

  • Total Income
    ₹505.77 Cr.
    (1058.61%)
  • Operating Profit
    ₹98.40 Cr.
    (4762.86%)
  • Profit After Tax
    ₹65.25 Cr.
    (3695.59%)
  • Operating Margin
    19.46%
    (13.13%)
Note: Comparison is on YoY basis

Quarterly - Aarti Pharmalabs Q4 Results

*All figures in crores except per share values
Fiscal PeriodMar 24Dec 23QoQ CompMar 23YoY Comp
Total Revenue 505.77448.6912.72%43.651058.61%
Selling/ General/ Admin Expenses Total 37.4036.163.43%1.861910.43%
Depreciation/ Amortization 19.1218.771.86%1.241447.18%
Other Operating Expenses Total 97.7372.4234.95%-15.180.00%
Total Operating Expense 407.37371.789.57%41.63878.56%
Operating Income 98.4076.9127.94%2.024762.86%
Net Income Before Taxes 95.7573.8229.71%1.815192.10%
Net Income 65.2552.7623.67%1.723695.59%
Diluted Normalized EPS 7.205.8223.71%2.56181.51%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanGet App